214 related articles for article (PubMed ID: 37550427)
1. Systemic administration of STING agonist promotes myeloid cells maturation and antitumor immunity through regulating hematopoietic stem and progenitor cell fate.
Xu T; Dai J; Tang L; Sun L; Si L; Guo J
Cancer Immunol Immunother; 2023 Nov; 72(11):3491-3505. PubMed ID: 37550427
[TBL] [Abstract][Full Text] [Related]
2. Dectin-1 Stimulation of Hematopoietic Stem and Progenitor Cells Occurs
Bono C; Martínez A; Megías J; Gozalbo D; Yáñez A; Gil ML
mBio; 2020 Jun; 11(3):. PubMed ID: 32576672
[TBL] [Abstract][Full Text] [Related]
3. The Aryl Hydrocarbon Receptor Modulates Murine Hematopoietic Stem Cell Homeostasis and Influences Lineage-Biased Stem and Progenitor Cells.
Vaughan KL; Franchini AM; Kern HG; Lawrence BP
Stem Cells Dev; 2021 Oct; 30(19):970-980. PubMed ID: 34428990
[TBL] [Abstract][Full Text] [Related]
4. Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source.
Hess NJ; Lindner PN; Vazquez J; Grindel S; Hudson AW; Stanic AK; Ikeda A; Hematti P; Gumperz JE
Front Immunol; 2020; 11():573406. PubMed ID: 33193358
[TBL] [Abstract][Full Text] [Related]
5. STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer.
Vonderhaar EP; Barnekow NS; McAllister D; McOlash L; Eid MA; Riese MJ; Tarakanova VL; Johnson BD; Dwinell MB
Cell Mol Gastroenterol Hepatol; 2021; 12(1):41-58. PubMed ID: 33548597
[TBL] [Abstract][Full Text] [Related]
6. Regulation of lymphoid-myeloid lineage bias through regnase-1/3-mediated control of Nfkbiz.
Uehata T; Yamada S; Ori D; Vandenbon A; Giladi A; Jelinski A; Murakawa Y; Watanabe H; Takeuchi K; Toratani K; Mino T; Kiryu H; Standley DM; Tsujimura T; Ikawa T; Kondoh G; Landthaler M; Kawamoto H; Rodewald HR; Amit I; Yamamoto R; Miyazaki M; Takeuchi O
Blood; 2024 Jan; 143(3):243-257. PubMed ID: 37922454
[TBL] [Abstract][Full Text] [Related]
7. Activation of Hematopoietic Stem/Progenitor Cells Promotes Immunosuppression Within the Pre-metastatic Niche.
Giles AJ; Reid CM; Evans JD; Murgai M; Vicioso Y; Highfill SL; Kasai M; Vahdat L; Mackall CL; Lyden D; Wexler L; Kaplan RN
Cancer Res; 2016 Mar; 76(6):1335-47. PubMed ID: 26719537
[TBL] [Abstract][Full Text] [Related]
8. Type II interferon promotes differentiation of myeloid-biased hematopoietic stem cells.
Matatall KA; Shen CC; Challen GA; King KY
Stem Cells; 2014 Nov; 32(11):3023-30. PubMed ID: 25078851
[TBL] [Abstract][Full Text] [Related]
9. The TLR1/2 agonist PAM(3)CSK(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate.
De Luca K; Frances-Duvert V; Asensio MJ; Ihsani R; Debien E; Taillardet M; Verhoeyen E; Bella C; Lantheaume S; Genestier L; Defrance T
Leukemia; 2009 Nov; 23(11):2063-74. PubMed ID: 19641520
[TBL] [Abstract][Full Text] [Related]
10. TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors.
Francica BJ; Ghasemzadeh A; Desbien AL; Theodros D; Sivick KE; Reiner GL; Hix Glickman L; Marciscano AE; Sharabi AB; Leong ML; McWhirter SM; Dubensky TW; Pardoll DM; Drake CG
Cancer Immunol Res; 2018 Apr; 6(4):422-433. PubMed ID: 29472271
[TBL] [Abstract][Full Text] [Related]
11. IL-1β expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC function.
Li S; Yao JC; Oetjen KA; Krambs JR; Xia J; Zhang J; Schmidt AP; Helton NM; Fulton RS; Heath SE; Turnbull IR; Mbalaviele G; Ley TJ; Walter MJ; Link DC
Blood; 2022 Oct; 140(14):1607-1620. PubMed ID: 35675516
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity.
Ager CR; Reilley MJ; Nicholas C; Bartkowiak T; Jaiswal AR; Curran MA
Cancer Immunol Res; 2017 Aug; 5(8):676-684. PubMed ID: 28674082
[TBL] [Abstract][Full Text] [Related]
13. TICAM-1 is dispensable in STING-mediated innate immune responses in myeloid immune cells.
Takashima K; Oshiumi H; Matsumoto M; Seya T
Biochem Biophys Res Commun; 2018 May; 499(4):985-991. PubMed ID: 29627569
[TBL] [Abstract][Full Text] [Related]
14. Oral
Marins-Dos-Santos A; Ayres-Silva JP; Antunes D; Moreira CJC; Pelajo-Machado M; Alfaro D; Zapata AG; Bonomo AC; Savino W; de Meis J; Farias-de-Oliveira DA
Front Cell Infect Microbiol; 2022; 12():800395. PubMed ID: 35402296
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy.
Jiang X; Wang J; Zheng X; Liu Z; Zhang X; Li Y; Wilhelm J; Cao J; Huang G; Zhang J; Sumer B; Lea J; Lu Z; Gao J; Luo M
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35623658
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer remotely imposes a myeloid bias on haematopoietic stem cells by reprogramming the bone marrow niche.
Gerber-Ferder Y; Cosgrove J; Duperray-Susini A; Missolo-Koussou Y; Dubois M; Stepaniuk K; Pereira-Abrantes M; Sedlik C; Lameiras S; Baulande S; Bendriss-Vermare N; Guermonprez P; Passaro D; Perié L; Piaggio E; Helft J
Nat Cell Biol; 2023 Dec; 25(12):1736-1745. PubMed ID: 38036749
[TBL] [Abstract][Full Text] [Related]
17. Promotion of Expansion and Differentiation of Hematopoietic Stem Cells by Interleukin-27 into Myeloid Progenitors to Control Infection in Emergency Myelopoiesis.
Furusawa J; Mizoguchi I; Chiba Y; Hisada M; Kobayashi F; Yoshida H; Nakae S; Tsuchida A; Matsumoto T; Ema H; Mizuguchi J; Yoshimoto T
PLoS Pathog; 2016 Mar; 12(3):e1005507. PubMed ID: 26991425
[TBL] [Abstract][Full Text] [Related]
18. IL-33-induced hematopoietic stem and progenitor cell mobilization depends upon CCR2.
Kim J; Kim W; Le HT; Moon UJ; Tran VG; Kim HJ; Jung S; Nguyen QT; Kim BS; Jun JB; Cho HR; Kwon B
J Immunol; 2014 Oct; 193(7):3792-802. PubMed ID: 25143444
[TBL] [Abstract][Full Text] [Related]
19. Unique molecular and functional features of extramedullary hematopoietic stem and progenitor cell reservoirs in humans.
Mende N; Bastos HP; Santoro A; Mahbubani KT; Ciaurro V; Calderbank EF; Quiroga Londoño M; Sham K; Mantica G; Morishima T; Mitchell E; Lidonnici MR; Meier-Abt F; Hayler D; Jardine L; Curd A; Haniffa M; Ferrari G; Takizawa H; Wilson NK; Göttgens B; Saeb-Parsy K; Frontini M; Laurenti E
Blood; 2022 Jun; 139(23):3387-3401. PubMed ID: 35073399
[TBL] [Abstract][Full Text] [Related]
20. Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4
Luo J; Pang S; Hui Z; Zhao H; Xu S; Yu W; Yang L; Sun Q; Hao X; Wei F; Wang J; Ren X
Theranostics; 2023; 13(14):4836-4857. PubMed ID: 37771774
[No Abstract] [Full Text] [Related]
[Next] [New Search]
